RRS® HA Long Lasting Triumphs as Best Injectable in Skin Revitalization at AMWC 2026
In a landmark achievement, Skin Tech Pharma Group has announced that its flagship product, RRS® HA Long Lasting, has been awarded the title of Best Injectable in Skin Revitalization at the prestigious Aesthetic Medicine World Congress (AMWC) 2026. This recognition places Skin Tech Pharma Group at the forefront of innovations in the skin-building sector.
RRS® HA Long Lasting was launched in 2021 and has rapidly gained a reputation as a trailblazer in the emerging Skin Builder category. As an incredible testament to its effectiveness, the product has facilitated more than one million treatments across the globe. Not only does it combine safety and clinical efficacy exceptionally well, but it also sets a new benchmark for aesthetic treatments by effectively improving skin quality while ensuring a natural-looking rejuvenation.
The accolade underscores the product's role in advancing regenerative aesthetic medicine, particularly given the rising consumer demand for solutions that promote natural results while focusing on long-lasting skin health, tissue quality, and graceful aging. ‘This award represents a significant achievement for us and reflects the strength of our long-term vision,’ expressed Márcio Rodrigues, CEO of Skin Tech Pharma Group. He elaborated on their ambition to lead through rigorous scientific methodologies, innovative products, and deep insights into the needs of healthcare providers, emphasizing their commitment to sustainable growth and enhanced standards of care in the industry.
RRS® HA Long Lasting is neither categorized strictly as a skin booster nor a dermal filler. Instead, it harmonizes desirable qualities from both classifications into a singular treatment methodology. This innovative injectable is a cross-linked hyaluronic acid skin builder, supplemented with a unique protective blend of 15 amino acids that bolster dermal structure. The result is improved hydration, an enhanced sense of firmness and texture, and a light lifting effect that alleviates wrinkles and fine lines.
Patients who undergo treatment with RRS® HA Long Lasting can expect to experience immediate and naturally pleasing results, coupled with progressive enhancements in skin quality over time. This holistic approach resonates well with today's aesthetic standards, fostering high patient satisfaction through visible improvements that extend beyond the clinic visit.
Dr. Javed Hussain, a Key Opinion Leader for Skin Tech Pharma Group, noted that, ‘Clinical practice has consistently demonstrated advancements in skin texture, elasticity, and overall luminosity. The hyaluronic acid foundation of RRS® HA Long Lasting, combined with its protective amino acid solution, fulfills the fundamental requirements needed to restore natural dermal function, which typically deteriorates with age.’ Dr. Hussain also emphasized the reproducibility of results, demonstrating reliability aligned with current safety standards while offering a level of durability not typically associated with standard skin boosters.
Focusing on delivering high-quality, evidence-based solutions worldwide, Skin Tech Pharma Group has earned its status as a leader in aesthetic medicine with 30 years of innovation since its inception in 1994 by Dr. Philippe Deprez. The establishment of Easy TCA® in 1996 marked a pivotal moment for the company, and it continues to innovate with its advanced laboratories and research teams dedicated to improving aesthetic performance through pharmaceutical rigor.
As it moves forward, Skin Tech Pharma Group remains committed to bridging aesthetic desires with scientifically-backed methodologies, ensuring that it continues to cater to the needs of both medical professionals and patients alike. The recognition of RRS® HA Long Lasting at the AMWC 2026 serves as a testament to the brand's tireless commitment to enhancing patient experiences and outcomes while leading the conversation in regenerative aesthetics.
For more information about RRS® HA Long Lasting and to explore the innovative offerings by Skin Tech Pharma Group, interested parties are encouraged to visit their official website.
RRS® HA Long Lasting was launched in 2021 and has rapidly gained a reputation as a trailblazer in the emerging Skin Builder category. As an incredible testament to its effectiveness, the product has facilitated more than one million treatments across the globe. Not only does it combine safety and clinical efficacy exceptionally well, but it also sets a new benchmark for aesthetic treatments by effectively improving skin quality while ensuring a natural-looking rejuvenation.
The accolade underscores the product's role in advancing regenerative aesthetic medicine, particularly given the rising consumer demand for solutions that promote natural results while focusing on long-lasting skin health, tissue quality, and graceful aging. ‘This award represents a significant achievement for us and reflects the strength of our long-term vision,’ expressed Márcio Rodrigues, CEO of Skin Tech Pharma Group. He elaborated on their ambition to lead through rigorous scientific methodologies, innovative products, and deep insights into the needs of healthcare providers, emphasizing their commitment to sustainable growth and enhanced standards of care in the industry.
RRS® HA Long Lasting is neither categorized strictly as a skin booster nor a dermal filler. Instead, it harmonizes desirable qualities from both classifications into a singular treatment methodology. This innovative injectable is a cross-linked hyaluronic acid skin builder, supplemented with a unique protective blend of 15 amino acids that bolster dermal structure. The result is improved hydration, an enhanced sense of firmness and texture, and a light lifting effect that alleviates wrinkles and fine lines.
Patients who undergo treatment with RRS® HA Long Lasting can expect to experience immediate and naturally pleasing results, coupled with progressive enhancements in skin quality over time. This holistic approach resonates well with today's aesthetic standards, fostering high patient satisfaction through visible improvements that extend beyond the clinic visit.
Dr. Javed Hussain, a Key Opinion Leader for Skin Tech Pharma Group, noted that, ‘Clinical practice has consistently demonstrated advancements in skin texture, elasticity, and overall luminosity. The hyaluronic acid foundation of RRS® HA Long Lasting, combined with its protective amino acid solution, fulfills the fundamental requirements needed to restore natural dermal function, which typically deteriorates with age.’ Dr. Hussain also emphasized the reproducibility of results, demonstrating reliability aligned with current safety standards while offering a level of durability not typically associated with standard skin boosters.
Focusing on delivering high-quality, evidence-based solutions worldwide, Skin Tech Pharma Group has earned its status as a leader in aesthetic medicine with 30 years of innovation since its inception in 1994 by Dr. Philippe Deprez. The establishment of Easy TCA® in 1996 marked a pivotal moment for the company, and it continues to innovate with its advanced laboratories and research teams dedicated to improving aesthetic performance through pharmaceutical rigor.
As it moves forward, Skin Tech Pharma Group remains committed to bridging aesthetic desires with scientifically-backed methodologies, ensuring that it continues to cater to the needs of both medical professionals and patients alike. The recognition of RRS® HA Long Lasting at the AMWC 2026 serves as a testament to the brand's tireless commitment to enhancing patient experiences and outcomes while leading the conversation in regenerative aesthetics.
For more information about RRS® HA Long Lasting and to explore the innovative offerings by Skin Tech Pharma Group, interested parties are encouraged to visit their official website.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.